Results 41 to 50 of about 672,479 (309)

Polymorphous Adenocarcinoma

open access: yesSurgical Pathology Clinics, 2021
Polymorphous adenocarcinoma (PAC) is typically originated from the minor salivary glands and is characterized by cytology uniformity and architectural diversity. PAC commonly harbors PRKD1 E710D mutation. PAC has an excellent prognosis. However, greater than or equal to 10% papillary or greater than or equal to 30% cribriform pattern is an independent ...
Nora, Katabi, Bin, Xu
openaire   +3 more sources

Defining and predicting very early recurrence after gastric surgery for gastric adenocarcinoma: a multi-institutional study. [PDF]

open access: yes, 2022
openSOMMARIO Presupposti dello studio: Il carcinoma gastrico rappresenta la quinta neoplasia più frequente al mondo ed è la quarta causa di morte correlata al cancro.
SONEGO, ARIANNA
core  

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Esophageal Carcinoma and Associated Risk Factors: A Case-control Study in Two Tertiary Care Hospitals of Kabul, Afghanistan

open access: yesCancer Management and Research, 2022
Ramin Saadaat,1 Jamshid Abdul-Ghafar,1 Ahmed Maseh Haidary,1 Nooria Atta,2 Tazeen Saeed Ali3 1Department of Pathology and Clinical Laboratory, French Medical Institute for Mothers and Children (FMIC), Kabul, Afghanistan; 2Department of Gynecology and ...
Saadaat R   +4 more
doaj  

Targeted Single Gene Mutation in Esophageal Adenocarcinoma

open access: yes, 2018
Esophageal adenocarcinoma is heterogeneous and studies have reviewed many important mutations that contribute to the pathogenesis of the cancer. These discoveries have helped paved the way into identifying new gene markers or gene targets to develop ...
Lam, AK   +7 more
core   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Adenocarcinoma do saco endolinfático: relato de caso

open access: yesArquivos de Neuro-Psiquiatria, 2002
Apresenta-se um caso de adenocarcinoma do saco endolinfático e revê-se a literatura. O quadro clínico manifestou-se por tonteira e perda progressiva da audição consequentes a tumor do saco endolinfático.
Silveira Roberto Leal   +3 more
doaj  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Case Report: Combined Small Cell Lung Carcinoma With Pulmonary Adenocarcinoma

open access: yesFrontiers in Surgery, 2022
BackgroundCombined small cell lung carcinoma is defined as cancer tissues that mainly contain small cell lung cancer (SCLC) components with non-SCLC (NSCLC) histopathological types.
Cheng Shen, Guowei Che
doaj   +1 more source

Application of Pathological Staging in Esophageal Adenocarcinoma

open access: yes, 2018
Staging is one of the most important factors that determine the prognosis of the patients with esophageal adenocarcinoma. The current staging protocol includes parameters—extent of tumor (T), lymph node status (N), presence of distant metastasis (M), and
Lam, AK, Lam, Alfred, Alfred K. Lam
core   +1 more source

Home - About - Disclaimer - Privacy